MedTrace Logo

A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy

NCT05345223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2024-12-20

No results posted yet for this study

Summary

The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan with patients' background and natural history of the disease, and to explore disease-specific prognostic factors.

Conditions

  • Triglyceride Deposit Cardiomyovasculopathy

Sponsors & Collaborators

  • Osaka University Graduate School of Medicine

    collaborator UNKNOWN

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Ken-ichi Hirano, MD, PhD · Department of Triglyceride Science, Graduate School of Medicine, Osaka University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05345223 on ClinicalTrials.gov